Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons
- 1 March 1993
- journal article
- Published by Elsevier in Neuroscience
- Vol. 53 (1) , 169-178
- https://doi.org/10.1016/0306-4522(93)90295-q
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Nigral degeneration in Parkinson's disease in relation to clinical featuresActa Neurologica Scandinavica, 1991
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- MPTP-induced parkinsonism in monkeys: Mechanism of action, selectivity and pathophysiologyGeneral Pharmacology: The Vascular System, 1988
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (mptp) and its relevance to parkinson's diseaseNeurochemistry International, 1987
- MPTP and its relevance to parkinson's diseaseNeurochemistry International, 1987
- “In vivo” visualization by positron emission tomography of the progressive striatal dopamine receptor damage occuring in MPTP-intoxicated non-human primatesLife Sciences, 1986
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeysLife Sciences, 1985
- I. Parkinson's disease: Studies with an animal modelLife Sciences, 1984